Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 5047898, 8 pages
https://doi.org/10.1155/2017/5047898
Research Article

Autoantibodies to NR2A Peptide of the Glutamate/NMDA Receptor in Patients with Seizure Disorders in Neuropsychiatric Systemic Lupus Erythematosus

1Guangdong No. 2 Provincial People’s Hospital, Courtyard No. 466, Middle Xingang Road, Haizhu District, Guangzhou 510317, China
2Department of Neurology, Nanfang Hospital, Southern Medical University, No. 1838 North Guangzhou Avenue, Guangzhou 510515, China
3TEDA International Cardiovascular Hospital, Medical College, Nankai University, Tianjin, China
4School of Public Health, Southern Medical University, No. 1023 South Shatai Rd., Guangzhou, Guangdong 510515, China
5Department of Histology and Embryology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China
6Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
7Department of Rheumatology, Nanfang Hospital, Southern Medical University, No. 1838 North Guangzhou Avenue, Guangzhou 510515, China

Correspondence should be addressed to Qin Huang; moc.liamxof@qhizniq

Received 4 September 2016; Accepted 15 December 2016; Published 5 January 2017

Academic Editor: Luc Vallières

Copyright © 2017 Yan Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yan Yang, Chao Yuan, Shu-qun Shen, et al., “Autoantibodies to NR2A Peptide of the Glutamate/NMDA Receptor in Patients with Seizure Disorders in Neuropsychiatric Systemic Lupus Erythematosus,” Mediators of Inflammation, vol. 2017, Article ID 5047898, 8 pages, 2017. doi:10.1155/2017/5047898